This episode provides a dense overview of the EU Medical Device Regulation (MDR 2017/745), a pivotal shift in European MedTech compliance. We explore the regulation's core pillars, from its emphasis on a total product lifecycle approach and stricter clinical data requirements to the challenges of device reclassification, the Notified Body bottleneck, and new transparency measures like EUDAMED and the UDI system. It’s a crucial guide for any manufacturer navigating this complex landscape. • What is the primary goal of Regulation (EU) 2017/745, the EU MDR? • How does the MDR shift focus from pre-approval to a total lifecycle approach? • Why are the new clinical evidence and Clinical Evaluation Report (CER) requirements so challenging? • What is the "Notified Body bottleneck" and how does it impact market entry timelines? • Are you aware of the extended transition deadlines and the critical dates from 2024? • What roles do the EUDAMED database and UDI system play in the new framework? • How does the MDR affect device classification and supply chain management? • Does your organization have a designated Person Responsible for Regulatory Compliance (PRRC)? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.